l 158809 has been researched along with Alloxan Diabetes in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, CH; Hong, SY; Kim, MJ; Lee, EY; Shim, MS; Shin, YG | 1 |
| Adler, SG; Cheon Park, H; Ha, SK; Han, DS; Kang, SW; Natarajan, R; Ryu, DR; Xu, ZG; Yoo, TH | 1 |
| Coppey, LJ; Davidson, EP; Gellett, JS; Lund, DD; Oltman, CL; Rinehart, TW; Yorek, MA | 1 |
| Buttrick, PM; Geenen, DL; Malhotra, A; Nakouzi, A; Reich, D; Sanghi, V | 1 |
4 other study(ies) available for l 158809 and Alloxan Diabetes
| Article | Year |
|---|---|
Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Experimental; Humans; Imidazoles; Kidney Glomerulus; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Vascular Endothelial Growth Factor A | 2004 |
Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Cycle Proteins; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Glucose; Imidazoles; Kidney; Kidney Glomerulus; Male; Mice; Rats; Streptozocin; Tetrazoles; Tumor Suppressor Proteins | 2005 |
ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Therapy, Combination; Enalapril; Imidazoles; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tetrazoles | 2006 |
Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade.
Topics: Angiotensin Receptor Antagonists; Animals; Diabetes Mellitus, Experimental; Female; Imidazoles; Isoenzymes; Myocardium; Phosphorylation; Protein Kinase C; Rats; Rats, Wistar; Streptozocin; Tetrazoles; Troponin I | 1997 |